ASSESSMENT OF TOBRAMYCIN DOSING IN CYSTIC FIBROSIS PATIENTS WITH ACUTE PULMONARY EXACERBATIONS

被引：0
|
作者：
Thirion, D. J. [1 ,2 ]
Koloskoff, K. [1 ]
Caissy, J. [1 ,2 ]
Matouk, E. [3 ]
Marsot, A. [1 ]
机构：
[1] Univ Montreal, Fac Pharm, Montreal, PQ, Canada
[2] McGill Univ, Ctr Hlth, Pharm, Montreal, PQ, Canada
[3] Montreal Chest Inst, Montreal, PQ, Canada
来源：
PEDIATRIC PULMONOLOGY | 2020年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
356
引用
收藏
页码：S177 / S178
页数：2
相关论文
共 50 条
  • [1] What is the recommended amikacin dosing for cystic fibrosis patients with acute pulmonary exacerbations?
    Thirion, Daniel J. G.
    Pasche, Valerian
    Marsot, Amelie
    [J]. PEDIATRIC PULMONOLOGY, 2019, 54 (11) : 1652 - 1653
  • [2] The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis
    Blumer, JL
    Saiman, L
    Konstan, MW
    Melnick, D
    [J]. CHEST, 2005, 128 (04) : 2336 - 2346
  • [3] COMPARISON OF 6 AND 8 HOURLY TOBRAMYCIN DOSING INTERVALS IN TREATMENT OF PULMONARY EXACERBATIONS IN CYSTIC-FIBROSIS PATIENTS
    WINNIE, GB
    COOPER, JA
    WITSON, J
    COWAN, RG
    MAYER, D
    LEPOW, M
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (05) : 381 - 386
  • [4] An evaluation of twice daily versus three times daily tobramycin dosing in pediatric cystic fibrosis patients experiencing acute pulmonary exacerbations
    Alspaugh, Kristen
    Hoge, Stephanie
    Patch, Megan
    Manasco, Kalen B.
    [J]. PHARMACOTHERAPY, 2013, 33 (10): : E291 - E291
  • [5] Consideration of height-based tobramycin dosing regimens for the treatment of adult cystic fibrosis pulmonary exacerbations
    El Hassani, Mehdi
    Simard, Chantale
    Pilote, Sylvie
    Cloutier, Isabelle
    Soufsaf, Sara
    Marsot, Amelie
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (05) : 2246 - 2255
  • [6] Evaluation of an empiric once daily tobramycin dosing regimen for pulmonary exacerbations in children and adults with cystic fibrosis
    VandenBussche, H. L.
    Marks, J. H.
    Homnick, D. N.
    [J]. PEDIATRIC PULMONOLOGY, 2007, : 321 - 321
  • [7] Tobramycin dosing in cystic fibrosis
    Smyth, A
    Touw, D
    Tan, KHV
    Bertenshaw, C
    Stableforth, D
    [J]. LANCET, 2005, 365 (9473): : 1767 - 1768
  • [8] Acute Pulmonary Exacerbations in Cystic Fibrosis
    Goss, Christopher H.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 40 (06) : 792 - 803
  • [9] EFFECT OF AZITHROMYCIN ON THE RESPONSE TO PULMONARY EXACERBATIONS TREATED WITH INTRAVENOUS TOBRAMYCIN IN PATIENTS WITH CYSTIC FIBROSIS
    Klingel, M.
    Ratjen, F.
    Stanojevic, S.
    Tullis, D. E.
    Nichols, D. P.
    Waters, V. J.
    [J]. PEDIATRIC PULMONOLOGY, 2017, 52 : S381 - S381
  • [10] TOBRAMYCIN AND TICARCILLIN THERAPY FOR EXACERBATIONS OF PULMONARY-DISEASE IN PATIENTS WITH CYSTIC-FIBROSIS
    PARRY, MF
    NEU, HC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1976, 134 : S194 - S199
12345